📰 Cm Life Sciences News
Page 2 - Cm Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cm Life Sciences. Real-time updates on events, politics, business and more.
April 29, 2023
Oak Street Health (NYSE:OSH – Get Rating) and GeneDx (NASDAQ:WGS – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Profitability This table compares Oak Street Health and GeneDx’s net […]
April 28, 2023
GeneDx Holdings Corp. (NASDAQ:WGS – Get Rating) shot up 3.5% during trading on Tuesday . The stock traded as high as $0.30 and last traded at $0.30. 2,943,442 shares were traded during mid-day trading, a decline of 25% from the average session volume of 3,940,957 shares. The stock had previously closed at $0.29. GeneDx Trading […]
April 7, 2023
GeneDx (NASDAQ:WGS – Get Rating) and Mitesco (OTCMKTS:MITI – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Risk & Volatility GeneDx has a beta of 1.91, suggesting that […]
April 2, 2023
Pear Therapeutics (NASDAQ:PEAR – Get Rating) and GeneDx (NASDAQ:WGS – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation. Analyst Recommendations This is a summary of recent recommendations for […]
March 25, 2023
Mitesco (OTCMKTS:MITI – Get Rating) and GeneDx (NASDAQ:WGS – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations. Insider and Institutional Ownership 3.5% of Mitesco shares are owned by […]
March 17, 2023
Mr Bates is facing allegations from high net worth investors that he failed to issue shares in Aurum+, despite claiming to have raised $15 million in investor capital.
January 15, 2023
SAN DIEGO, Jan. 14, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection...
June 6, 2022
A number of firms have modified their ratings and price targets on shares of Sema4 (NASDAQ: SMFR) recently: 6/2/2022 – Sema4 is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $3.50 price target on the stock. 5/25/2022 – Sema4 was upgraded by analysts at Zacks Investment […]
May 25, 2022
Research Analysts’ upgrades for Tuesday, May 24th: Adicet Bio (NASDAQ:ACET) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Assembly Biosciences (NASDAQ:ASMB) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Cadiz (NASDAQ:CDZI) was upgraded by analysts at StockNews.com to a sell rating. Consolidated Water […]
May 25, 2022
EQRx (NASDAQ:EQRX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. The firm presently has a $4.75 price target on the stock. Zacks Investment Research‘s price target points to a potential upside of 10.47% […]